Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 104.70

+0.5%

11:28 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (751)	12/8/1998 3:48:00 PM
From: nigel bates	Read Replies (2) of 3202

>>But, INCY Genetics also gets the future DiaDexus plum, which will ultimately be a major score in diagnostics.<< (Rman., Oct 20th) Looks like it might be on the verge of scoring. The UK Cancer Research Campaign has licensed diaDexus to commercialise a cervical cancer screening test whose development they funded at Cambridge University. This has big political backing in the UK - the Health Secretary attended the press conference announcing the new test, & the unreliability of the Pap test currently used is a political hot potato. "No financial consideration will delay the introduction of this test in Britain" according to the minister. nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next